首页 > 最新文献

Indian heart journal最新文献

英文 中文
Hypertonic saline in acute decompensated heart failure (HSHF). 高渗盐水治疗急性失代偿性心力衰竭 (HSHF)。
IF 1.4 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-11-01 Epub Date: 2024-11-22 DOI: 10.1016/j.ihj.2024.11.246
Shweta Agrawal, Sunil Abhishek Batta, Tarun Rao, Sumithra Selvam

Hypertonic saline with high dose furosemide improves refractory heart failure. In this case series of 10 patients of refractory acute decompensated heart failure, effect of HSS with furosemide was compared with furosemide alone. Patients responded to the therapy better, with faster decongestion, without significant adverse effects or worsening renal function. Hence an adequately powered, randomized study is required to assess the veracity of findings in this case series of hypertonic saline in diuretic resistant acute decompensated heart failure on optimal therapy. Based on present study, hypertonic saline looks like a promising option in the management of refractory heart failure.

高渗盐水联合大剂量呋塞米可改善难治性心力衰竭。在这组 10 例难治性急性失代偿性心力衰竭患者的病例中,高渗盐水联合呋塞米与单独使用呋塞米的效果进行了比较。患者对该疗法的反应更好,减充血更快,且无明显不良反应或肾功能恶化。因此,需要进行充分有效的随机研究,以评估高渗盐水治疗利尿剂耐药的急性失代偿性心力衰竭最佳疗法系列病例研究结果的真实性。根据目前的研究,高渗盐水似乎是治疗难治性心力衰竭的一种很有前景的选择。
{"title":"Hypertonic saline in acute decompensated heart failure (HSHF).","authors":"Shweta Agrawal, Sunil Abhishek Batta, Tarun Rao, Sumithra Selvam","doi":"10.1016/j.ihj.2024.11.246","DOIUrl":"10.1016/j.ihj.2024.11.246","url":null,"abstract":"<p><p>Hypertonic saline with high dose furosemide improves refractory heart failure. In this case series of 10 patients of refractory acute decompensated heart failure, effect of HSS with furosemide was compared with furosemide alone. Patients responded to the therapy better, with faster decongestion, without significant adverse effects or worsening renal function. Hence an adequately powered, randomized study is required to assess the veracity of findings in this case series of hypertonic saline in diuretic resistant acute decompensated heart failure on optimal therapy. Based on present study, hypertonic saline looks like a promising option in the management of refractory heart failure.</p>","PeriodicalId":13384,"journal":{"name":"Indian heart journal","volume":" ","pages":"418-420"},"PeriodicalIF":1.4,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11705591/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142695494","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Incidence of infective endocarditis in patients with hypertrophic cardiomyopathy. 肥厚型心肌病患者感染性心内膜炎的发病率。
IF 1.4 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-11-01 Epub Date: 2024-11-24 DOI: 10.1016/j.ihj.2024.11.332
Somyata Somendra, Saurabh Mehrotra, Parag Barwad, Himanshu Gupta, Ajay Bahl

Background: Data on the incidence of infective endocarditis (IE) in patients with hypertrophic cardiomyopathy (HCM) is sparse. This study evaluated a HCM cohort with aim to study the incidence of IE in these patients.

Methods: All patients entering the HCM cohort from May 2003 to June 2022 of a tertiary care hospital with at least one follow-up visit were included and followed up till June 2023. This was a retrospective cohort analysis. Only individuals who were diagnosed with IE after entry into the cohort were included.

Results: The study cohort consisted of 529 HCM patients with a total follow up duration of 3244.6 years. The mean and median follow-up durations were 6.1 ± 4.7 and 5.3 (range 31 days to 20.1) years respectively. Three (0.57 %) patients in the cohort developed IE. Incidence of IE in HCM patients was 0.92/1000 patient years. Two patients had left ventricular outflow tract obstruction while one had non-obstructive HCM. None of the patients with isolated mid-cavity gradients developed IE. The incidence of IE in the obstructive and nonobstructive groups was 1.39 and 0.55 per 1000 patient years respectively. Two had vegetations on mitral valve while one had vegetations on aortic valve. Both patients with mitral valve endocarditis developed severe residual mitral regurgitation and heart failure.

Conclusions: IE is a rare complication in HCM patients with an incidence of 0.92/1000 patient years. However, when it occurs, IE is associated with high morbidity and mortality.

背景:有关肥厚型心肌病(HCM)患者感染性心内膜炎(IE)发病率的数据很少。本研究对肥厚型心肌病队列进行了评估,旨在研究这些患者的感染性心内膜炎发病率:方法:纳入 2003 年 5 月至 2022 年 6 月在一家三级医院就诊并至少接受过一次随访的所有 HCM 患者,并随访至 2023 年 6 月。这是一项回顾性队列分析。只有在进入队列后被确诊为 IE 的患者才被纳入:研究队列由 529 名 HCM 患者组成,总随访时间为 3244.6 年。平均和中位随访时间分别为 6.1 ± 4.7 年和 5.3 年(31 天至 20.1 年不等)。队列中有三名患者(0.57%)发生了 IE。HCM 患者的 IE 发生率为 0.92/1000 患者年。两名患者患有左心室流出道梗阻,一名患者患有非梗阻性 HCM。孤立中腔梯度患者中没有一人发生 IE。阻塞组和非阻塞组的 IE 发生率分别为每 1000 患者年 1.39 例和 0.55 例。两名患者的二尖瓣上长有植被,一名患者的主动脉瓣上长有植被。两名二尖瓣心内膜炎患者都出现了严重的二尖瓣残余反流和心力衰竭:二尖瓣内膜炎在 HCM 患者中是一种罕见的并发症,发病率为 0.92/1000。然而,一旦发生,IE 的发病率和死亡率都很高。
{"title":"Incidence of infective endocarditis in patients with hypertrophic cardiomyopathy.","authors":"Somyata Somendra, Saurabh Mehrotra, Parag Barwad, Himanshu Gupta, Ajay Bahl","doi":"10.1016/j.ihj.2024.11.332","DOIUrl":"10.1016/j.ihj.2024.11.332","url":null,"abstract":"<p><strong>Background: </strong>Data on the incidence of infective endocarditis (IE) in patients with hypertrophic cardiomyopathy (HCM) is sparse. This study evaluated a HCM cohort with aim to study the incidence of IE in these patients.</p><p><strong>Methods: </strong>All patients entering the HCM cohort from May 2003 to June 2022 of a tertiary care hospital with at least one follow-up visit were included and followed up till June 2023. This was a retrospective cohort analysis. Only individuals who were diagnosed with IE after entry into the cohort were included.</p><p><strong>Results: </strong>The study cohort consisted of 529 HCM patients with a total follow up duration of 3244.6 years. The mean and median follow-up durations were 6.1 ± 4.7 and 5.3 (range 31 days to 20.1) years respectively. Three (0.57 %) patients in the cohort developed IE. Incidence of IE in HCM patients was 0.92/1000 patient years. Two patients had left ventricular outflow tract obstruction while one had non-obstructive HCM. None of the patients with isolated mid-cavity gradients developed IE. The incidence of IE in the obstructive and nonobstructive groups was 1.39 and 0.55 per 1000 patient years respectively. Two had vegetations on mitral valve while one had vegetations on aortic valve. Both patients with mitral valve endocarditis developed severe residual mitral regurgitation and heart failure.</p><p><strong>Conclusions: </strong>IE is a rare complication in HCM patients with an incidence of 0.92/1000 patient years. However, when it occurs, IE is associated with high morbidity and mortality.</p>","PeriodicalId":13384,"journal":{"name":"Indian heart journal","volume":" ","pages":"405-407"},"PeriodicalIF":1.4,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11705623/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142716269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Influenza vaccine in cardiovascular disease: Current evidence and practice in India. 心血管疾病中的流感疫苗:印度目前的证据和实践。
IF 1.4 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-11-01 Epub Date: 2024-11-28 DOI: 10.1016/j.ihj.2024.11.247
Ambuj Roy, Satyavir Yadav

Influenza is a common trigger for cardiovascular events. Temporal association studies of influenza and cardiovascular events have well documented this phenomenon. More recently, randomised clinical trials of influenza vaccine have shown the benefit of immunisation in reducing recurrent cardiovascular events, especially in patients with acute coronary syndrome. Despite this overwhelming benefit, its uptake in India is very low. This could be due to a lack of awareness and paucity of evidence of its benefit in tropical countries like India, where the influenza season is variable and spread throughout the year. In this review, we explore these aspects of influenza and cardiovascular diseases and discuss the way ahead.

流感是心血管事件的常见诱因。流感和心血管事件的时间关联研究充分证明了这一现象。最近,流感疫苗的随机临床试验显示免疫接种在减少复发性心血管事件方面的益处,特别是在急性冠状动脉综合征患者中。尽管有如此巨大的好处,但它在印度的使用率非常低。这可能是由于在印度等热带国家缺乏认识和缺乏证据证明其益处,在这些国家,流感季节是多变的,并且全年都在蔓延。在这篇综述中,我们探讨了流感和心血管疾病的这些方面,并讨论了未来的发展方向。
{"title":"Influenza vaccine in cardiovascular disease: Current evidence and practice in India.","authors":"Ambuj Roy, Satyavir Yadav","doi":"10.1016/j.ihj.2024.11.247","DOIUrl":"10.1016/j.ihj.2024.11.247","url":null,"abstract":"<p><p>Influenza is a common trigger for cardiovascular events. Temporal association studies of influenza and cardiovascular events have well documented this phenomenon. More recently, randomised clinical trials of influenza vaccine have shown the benefit of immunisation in reducing recurrent cardiovascular events, especially in patients with acute coronary syndrome. Despite this overwhelming benefit, its uptake in India is very low. This could be due to a lack of awareness and paucity of evidence of its benefit in tropical countries like India, where the influenza season is variable and spread throughout the year. In this review, we explore these aspects of influenza and cardiovascular diseases and discuss the way ahead.</p>","PeriodicalId":13384,"journal":{"name":"Indian heart journal","volume":" ","pages":"365-369"},"PeriodicalIF":1.4,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11705601/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142755077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
National experience of alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: A long-term multicenter retrospective study. 全国阻塞性肥厚型心肌病患者酒精室间隔消融术的经验:一项长期多中心回顾性研究。
IF 1.4 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-11-01 Epub Date: 2024-11-22 DOI: 10.1016/j.ihj.2024.11.248
Evgenii Shloido, Kirill Popov, Sergey Chernyshov, Maksim Kashtanov

Objectives: Hypertrophic cardiomyopathy (HCM) is a widespread disease with an incidence of 1:200 in the general population and its surgical and interventional treatment is well-developed in western countries. This study is focusing on outcomes of HCM patients after alcohol septal ablation in Russian Federation.

Methods: We conducted a multicenter registry to evaluate outcomes of obstructive hypertrophic cardiomyopathy (oHCM) patients after ASA. Our study was focused on the following outcomes: (i) 30-day mortality, (ii) 30-day permanent pacemaker implantations, (iii) a residual obstruction occurrence, (iv) final maximal left ventricular outflow tract gradient, (v) long-term mortality, (vi) final heart failure functional class, (vii) freedom from sudden cardiac death. We conducted secondary analysis to assess outcomes in patients with single versus repeated ASA. The mean follow-up was 71 ± 47 months.

Results: A total of 597 consecutive patients (54.9 % female) were enrolled in the Russian Alcohol Septal Reduction (RASA) registry from three interventional groups. The mean age was 56 ± 14 years. Thirty-day mortality rate was 0.7 % (4 patients). Permanent pacemakers were implanted in 42 (7 %) cases in 30-days follow-up. The resting LVOT gradient reduced from 64 ± 28 to 20 ± 13 mmHg (p < 0.0001), and the mean NYHA class decreased from 2.3 ± 0.7 to 1.3 ± 0.5 (p < 0.001). Long-term survival rates were as follows: 97.4 (95%CI: 96.2-98.7) %, 93.2 (95%CI: 91.0-95.3) %, 84.9 (95%CI: 80.7-89.4) % at 1-, 5-, 10-year follow-up, respectively. Patients after repeated ASA. had similar long-term survival comparing to those who underwent single ASA (weighted log rank p value = 0.254). Heart failure class in the long-term and final gradient at the last follow-up were not statistically different between groups under study (p > 0.05).

Conclusions: In our registry, alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy was safe in the short- and long-term follow-up. Outcomes of patients underwent repeated ASA were non-inferior to those after single ASA.

目的:肥厚型心肌病(HCM)是一种广泛存在的疾病,在普通人群中的发病率为 1:200,其手术和介入治疗在西方国家非常发达。本研究的重点是俄罗斯联邦酒精室间隔消融术后 HCM 患者的治疗效果:我们进行了一项多中心登记,以评估阻塞性肥厚型心肌病(oHCM)患者接受 ASA 治疗后的效果。我们的研究主要关注以下结果:(i) 30 天死亡率,(ii) 30 天永久起搏器植入情况,(iii) 剩余梗阻发生情况,(iv) 最终最大左室流出道梯度,(v) 长期死亡率,(vi) 最终心衰功能分级,(vii) 免于心脏性猝死。我们进行了二次分析,以评估单次与重复 ASA 患者的预后。平均随访时间为 71±47 个月:俄罗斯酒精隔膜缩窄术(RASA)登记处共登记了来自三个介入组的 597 名连续患者(54.9% 为女性)。平均年龄为 56±14 岁。30 天死亡率为 0.7%(4 名患者)。在30天的随访中,42例(7%)患者植入了永久起搏器。静息左心室出口梯度从 64±28 mmHg 降至 20±13 mmHg(P0.05):在我们的登记中,阻塞性肥厚型心肌病患者的酒精室间隔消融术在短期和长期随访中都是安全的。结论:在我们的登记中,阻塞性肥厚型心肌病患者的酒精隔间消融术在短期和长期随访中都是安全的。
{"title":"National experience of alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: A long-term multicenter retrospective study.","authors":"Evgenii Shloido, Kirill Popov, Sergey Chernyshov, Maksim Kashtanov","doi":"10.1016/j.ihj.2024.11.248","DOIUrl":"10.1016/j.ihj.2024.11.248","url":null,"abstract":"<p><strong>Objectives: </strong>Hypertrophic cardiomyopathy (HCM) is a widespread disease with an incidence of 1:200 in the general population and its surgical and interventional treatment is well-developed in western countries. This study is focusing on outcomes of HCM patients after alcohol septal ablation in Russian Federation.</p><p><strong>Methods: </strong>We conducted a multicenter registry to evaluate outcomes of obstructive hypertrophic cardiomyopathy (oHCM) patients after ASA. Our study was focused on the following outcomes: (i) 30-day mortality, (ii) 30-day permanent pacemaker implantations, (iii) a residual obstruction occurrence, (iv) final maximal left ventricular outflow tract gradient, (v) long-term mortality, (vi) final heart failure functional class, (vii) freedom from sudden cardiac death. We conducted secondary analysis to assess outcomes in patients with single versus repeated ASA. The mean follow-up was 71 ± 47 months.</p><p><strong>Results: </strong>A total of 597 consecutive patients (54.9 % female) were enrolled in the Russian Alcohol Septal Reduction (RASA) registry from three interventional groups. The mean age was 56 ± 14 years. Thirty-day mortality rate was 0.7 % (4 patients). Permanent pacemakers were implanted in 42 (7 %) cases in 30-days follow-up. The resting LVOT gradient reduced from 64 ± 28 to 20 ± 13 mmHg (p < 0.0001), and the mean NYHA class decreased from 2.3 ± 0.7 to 1.3 ± 0.5 (p < 0.001). Long-term survival rates were as follows: 97.4 (95%CI: 96.2-98.7) %, 93.2 (95%CI: 91.0-95.3) %, 84.9 (95%CI: 80.7-89.4) % at 1-, 5-, 10-year follow-up, respectively. Patients after repeated ASA. had similar long-term survival comparing to those who underwent single ASA (weighted log rank p value = 0.254). Heart failure class in the long-term and final gradient at the last follow-up were not statistically different between groups under study (p > 0.05).</p><p><strong>Conclusions: </strong>In our registry, alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy was safe in the short- and long-term follow-up. Outcomes of patients underwent repeated ASA were non-inferior to those after single ASA.</p>","PeriodicalId":13384,"journal":{"name":"Indian heart journal","volume":" ","pages":"390-397"},"PeriodicalIF":1.4,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11705596/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142709959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current practices and knowledge of home blood pressure monitoring among people with hypertension: Insights from a Multicentric study from North India. 高血压患者家庭血压监测的当前做法和知识:印度北部一项多中心研究的启示。
IF 1.4 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-11-01 Epub Date: 2024-11-22 DOI: 10.1016/j.ihj.2024.11.249
Akash Batta, Anusha Singhania, Sarit Sharma, Singal Gautam, Ankur Singla, Harsimran Kalsi, Diksha Mahendru, Samneet Singh, Ishaan Goyal, Hiyanoor Ghosh, Aditya Uppal, Nishma Dhand, Namita Bansal, Anurag Chaudhary, Gurpreet Singh Wander, Sivasubramanian Ramakrishnan, Bishav Mohan

Objectives: Hypertension (HTN) management guidelines recommend home blood pressure monitoring (HBPM) as an important tool for BP control. Limited data exists on HBPM epidemiology among people with HTN and their caregivers in the Indian context.

Methods: The current study was conducted across three North Indian centres to evaluate the prevalence, training and technique of HBPM among people with HTN and their caregivers. People with diagnosed HTN (>3 months duration) and their caregivers, were screened and their HBPM use was evaluated. HBPM practices were assessed by observing participants measuring BP using a pre-validated, structured 16-point observational checklist. HBPM knowledge was assessed using a 19-point self-administered questionnaire based on the most recent AHA guidelines. Responses were graded and classified based on quartiles.

Results: A total of 2750 participants were screened, of which 2588 (2070 from urban and 518 from rural areas) were included. A total of 468 (18.1 %) were using HBPM. The proportion of respondents using HBPM was 20.5 % (424/2070) in urban, and 8.5 % (44/518) in rural areas. Only 24.7 % (n = 116) of the 468 participants (236 patients and 232 caregivers) using HBPM at home recalled ever receiving training from any healthcare workers. The majority (75.2 %, 352/468) of participants reported learning HBPM themselves through observation, videos, and reading. In HBPM practice assessment, 15.9 % of people with HTN (37/232) vs 5.9 % caregivers (14/236) scored excellent (score >75 %). In HPBM knowledge assessment, 0.4 % of people with HTN (1/232) vs no caregivers scored excellent. HPBM practices were better than knowledge, with mean scores of 62.3 ± 13.1 % and 40.1 ± 16.2 % respectively. Higher education level was associated with improved patient knowledge (p = 0.041), but not practices (p = 0.225).

Conclusions: There is need for more robust training on HBPM to enable people from all backgrounds to better manage their HTN, especially in rural areas. Education is not a barrier to learning good HBPM technique.

目的:高血压(HTN)管理指南建议将家庭血压监测(HBPM)作为控制血压的重要工具。在印度,关于高血压患者及其护理人员的家庭血压监测流行病学数据有限:本研究在北印度的三个中心进行,目的是评估高血压患者及其护理人员中 HBPM 的流行率、培训和技术。对确诊为高血压患者(病程超过 3 个月)及其护理人员进行了筛查,并对他们使用 HBPM 的情况进行了评估。通过使用预先验证的结构化 16 点观察核对表观察参与者测量血压,评估 HBPM 的使用情况。根据最新的 AHA 指南,使用 19 分自填式问卷对 HBPM 知识进行评估。结果:结果:共筛选出 2750 名参与者,其中 2588 人(2070 人来自城市地区,518 人来自农村地区)被纳入其中。共有 468 人(18.1%)使用 HBPM。城市地区使用 HBPM 的受访者比例为 20.5%(424/2070),农村地区为 8.5%(44/518)。在 468 名在家使用 HBPM 的受访者(236 名患者和 232 名护理人员)中,只有 24.7%(n=116)回忆起曾接受过任何医护人员的培训。大多数参与者(75.2%,352/468)表示自己是通过观察、视频和阅读来学习 HBPM 的。在 HBPM 实践评估中,15.9% 的高血压患者(37/232)和 5.9% 的护理人员(14/236)获得了优秀(得分大于 75%)。在 HPBM 知识评估中,0.4% 的高血压患者(1/232)与没有护理人员得分优秀。HPBM实践优于知识,平均得分分别为62.3±13.1%和40.1±16.2%。较高的教育水平与患者知识水平的提高相关(p=0.041),但与实践水平的提高无关(p=0.225):结论:有必要加强 HBPM 培训,使各种背景的人都能更好地管理高血压,尤其是在农村地区。教育并不是学习良好 HBPM 技术的障碍。
{"title":"Current practices and knowledge of home blood pressure monitoring among people with hypertension: Insights from a Multicentric study from North India.","authors":"Akash Batta, Anusha Singhania, Sarit Sharma, Singal Gautam, Ankur Singla, Harsimran Kalsi, Diksha Mahendru, Samneet Singh, Ishaan Goyal, Hiyanoor Ghosh, Aditya Uppal, Nishma Dhand, Namita Bansal, Anurag Chaudhary, Gurpreet Singh Wander, Sivasubramanian Ramakrishnan, Bishav Mohan","doi":"10.1016/j.ihj.2024.11.249","DOIUrl":"10.1016/j.ihj.2024.11.249","url":null,"abstract":"<p><strong>Objectives: </strong>Hypertension (HTN) management guidelines recommend home blood pressure monitoring (HBPM) as an important tool for BP control. Limited data exists on HBPM epidemiology among people with HTN and their caregivers in the Indian context.</p><p><strong>Methods: </strong>The current study was conducted across three North Indian centres to evaluate the prevalence, training and technique of HBPM among people with HTN and their caregivers. People with diagnosed HTN (>3 months duration) and their caregivers, were screened and their HBPM use was evaluated. HBPM practices were assessed by observing participants measuring BP using a pre-validated, structured 16-point observational checklist. HBPM knowledge was assessed using a 19-point self-administered questionnaire based on the most recent AHA guidelines. Responses were graded and classified based on quartiles.</p><p><strong>Results: </strong>A total of 2750 participants were screened, of which 2588 (2070 from urban and 518 from rural areas) were included. A total of 468 (18.1 %) were using HBPM. The proportion of respondents using HBPM was 20.5 % (424/2070) in urban, and 8.5 % (44/518) in rural areas. Only 24.7 % (n = 116) of the 468 participants (236 patients and 232 caregivers) using HBPM at home recalled ever receiving training from any healthcare workers. The majority (75.2 %, 352/468) of participants reported learning HBPM themselves through observation, videos, and reading. In HBPM practice assessment, 15.9 % of people with HTN (37/232) vs 5.9 % caregivers (14/236) scored excellent (score >75 %). In HPBM knowledge assessment, 0.4 % of people with HTN (1/232) vs no caregivers scored excellent. HPBM practices were better than knowledge, with mean scores of 62.3 ± 13.1 % and 40.1 ± 16.2 % respectively. Higher education level was associated with improved patient knowledge (p = 0.041), but not practices (p = 0.225).</p><p><strong>Conclusions: </strong>There is need for more robust training on HBPM to enable people from all backgrounds to better manage their HTN, especially in rural areas. Education is not a barrier to learning good HBPM technique.</p>","PeriodicalId":13384,"journal":{"name":"Indian heart journal","volume":" ","pages":"398-404"},"PeriodicalIF":1.4,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11705592/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142695490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Morphological characterization of coronary plaques in young indian patients with acute coronary syndrome: A multicentric study. 印度年轻急性冠状动脉综合征患者冠状动脉斑块的形态特征:一项多中心研究
IF 1.4 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-11-01 Epub Date: 2024-11-03 DOI: 10.1016/j.ihj.2024.11.001
Upendra Kaul, Rishi Sethi, Sanjeeb Roy, P K Goel, Nagendra Singh Chouhan, Rajesh Vijayvergiya, Manish Narang, Priyadarshini, D K Baruah, Rony Mathew

Objectives: The prevalence of atherosclerosis and acute coronary syndrome (ACS) is increasing in young Indians (18-50 years of age). However, the characteristics of atherosclerotic plaques in such individuals are poorly understood, presenting distinct challenges for the management of ACS. This study aims to analyze plaque characteristics in young Indian patients with ACS who underwent percutaneous coronary intervention (PCI) using optical coherence tomography (OCT) imaging.

Methods: This was a prospective, multicentric, non-interventional study on patients aged 18-50 years presenting with ST-elevation myocardial infarction (STEMI), non-ST elevation myocardial infarction, or unstable angina, and were scheduled to undergo OCT-guided PCI. Major adverse cardiac events (MACE) were assessed post-procedure and at the 6-month and 12-month follow-ups.

Results: The study included 100 ACS patients (mean age = 43.6 ± 5.2 years), with 51% presenting with STEMI. Pre-PCI OCT assessment showed that fibrous plaques (75%) were most common followed by plaques containing macrophages (27%), microchannels (20%), and calcified nodules (14%). In addition, plaque rupture, plaque erosion, and lipid-rich plaques, along with red, white, and mixed thrombi, were observed in 31%, 25%, 24%, 21%, 14%, and 17% (total thrombus occurrence = 52%) of the patients, respectively. At 12 months, the MACE (coronary artery bypass graft) rate was 1%.

Conclusions: Young Indian patients with ACS displayed a range of plaque morphologies identified through pre-PCI OCT. Among these, fibrous plaques were the most prominent type, followed by plaques containing macrophages. Additionally, plaque rupture, plaque erosion, and lipid-rich plaques were also observed in this population.

目的:动脉粥样硬化和急性冠状动脉综合征(ACS)在印度年轻人(18-50 岁)中的发病率越来越高。然而,人们对这类人群动脉粥样硬化斑块的特征知之甚少,这给急性冠状动脉综合征的治疗带来了独特的挑战。本研究旨在利用光学相干断层扫描(OCT)成像技术分析接受经皮冠状动脉介入治疗(PCI)的印度年轻 ACS 患者的斑块特征:这是一项前瞻性、多中心、非介入性研究,研究对象为18-50岁的ST段抬高型心肌梗死(STEMI)、非ST段抬高型心肌梗死或不稳定型心绞痛患者,并计划在OCT引导下接受PCI治疗。术后及6个月和12个月随访时对主要心脏不良事件(MACE)进行评估:研究纳入了100名ACS患者(平均年龄=43.6±5.2岁),其中51%为STEMI患者。PCI前的OCT评估显示,纤维斑块(75%)最常见,其次是含有巨噬细胞的斑块(27%)、微通道(20%)和钙化结节(14%)。此外,分别有31%、25%、24%、21%、14%和17%的患者(血栓总发生率=52%)观察到斑块破裂、斑块侵蚀和富脂斑块,以及红色、白色和混合血栓。12个月后,MACE冠状动脉搭桥术(CABG)发生率为1%:通过PCI前OCT检查,印度年轻的ACS患者显示出一系列斑块形态。其中,纤维斑块是最突出的类型,其次是含有巨噬细胞的斑块。此外,在该人群中还观察到斑块破裂、斑块侵蚀和富脂斑块。
{"title":"Morphological characterization of coronary plaques in young indian patients with acute coronary syndrome: A multicentric study.","authors":"Upendra Kaul, Rishi Sethi, Sanjeeb Roy, P K Goel, Nagendra Singh Chouhan, Rajesh Vijayvergiya, Manish Narang, Priyadarshini, D K Baruah, Rony Mathew","doi":"10.1016/j.ihj.2024.11.001","DOIUrl":"10.1016/j.ihj.2024.11.001","url":null,"abstract":"<p><strong>Objectives: </strong>The prevalence of atherosclerosis and acute coronary syndrome (ACS) is increasing in young Indians (18-50 years of age). However, the characteristics of atherosclerotic plaques in such individuals are poorly understood, presenting distinct challenges for the management of ACS. This study aims to analyze plaque characteristics in young Indian patients with ACS who underwent percutaneous coronary intervention (PCI) using optical coherence tomography (OCT) imaging.</p><p><strong>Methods: </strong>This was a prospective, multicentric, non-interventional study on patients aged 18-50 years presenting with ST-elevation myocardial infarction (STEMI), non-ST elevation myocardial infarction, or unstable angina, and were scheduled to undergo OCT-guided PCI. Major adverse cardiac events (MACE) were assessed post-procedure and at the 6-month and 12-month follow-ups.</p><p><strong>Results: </strong>The study included 100 ACS patients (mean age = 43.6 ± 5.2 years), with 51% presenting with STEMI. Pre-PCI OCT assessment showed that fibrous plaques (75%) were most common followed by plaques containing macrophages (27%), microchannels (20%), and calcified nodules (14%). In addition, plaque rupture, plaque erosion, and lipid-rich plaques, along with red, white, and mixed thrombi, were observed in 31%, 25%, 24%, 21%, 14%, and 17% (total thrombus occurrence = 52%) of the patients, respectively. At 12 months, the MACE (coronary artery bypass graft) rate was 1%.</p><p><strong>Conclusions: </strong>Young Indian patients with ACS displayed a range of plaque morphologies identified through pre-PCI OCT. Among these, fibrous plaques were the most prominent type, followed by plaques containing macrophages. Additionally, plaque rupture, plaque erosion, and lipid-rich plaques were also observed in this population.</p>","PeriodicalId":13384,"journal":{"name":"Indian heart journal","volume":" ","pages":"370-375"},"PeriodicalIF":1.4,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11705610/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142583118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Attainment of low-density lipoprotein cholesterol goals in patients undergoing coronary revascularization in the contemporary clinical practice. 在当代临床实践中,接受冠状动脉血运重建的患者能否达到低密度脂蛋白胆固醇目标。
IF 1.4 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-11-01 Epub Date: 2024-11-20 DOI: 10.1016/j.ihj.2024.11.244
Manish Bansal, Ravi R Kasliwal, Praveen Chandra, Rajneesh Kapoor, Nagendra Chouhan, Anil Bhan, Naresh Trehan

This study aimed to assess the effectiveness of current lipid-lowering therapy in achieving low-density lipoprotein cholesterol (LDL-C) goals in Indian patients undergoing coronary revascularization. Consecutive subjects (n = 1275, mean age 60.0 ± 9.7 years, 87.2 % men) with newly diagnosed coronary artery disease and undergoing coronary revascularization during the period 1 Jan 2023 to 31 Dec 2023 were included. After a median follow-up of 99 days (interquartile range 91-109 days), the mean LDL-C was 63.9 ± 24.3 mg/dL with 67.5% and 29.9% of subjects having LDL-C <70 mg/dL and <50 mg/dL, respectively. These proportions were 70.8% and 32.1% for patients treated with high-intensity statin therapy (rosuvastatin 20-40 mg/d or atorvastatin 40-80 mg/d). Among patients treated with rosuvastatin 40 mg/d and ezetimibe 10 mg/d, 53.3% achieved LDL-C <50 mg/dL. These findings underscore the need for greater usage of combination lipid-lowering therapy and agents with high LDL-C lowering efficacy.

本研究旨在评估目前的降脂疗法在实现接受冠状动脉血运重建术的印度患者的低密度脂蛋白胆固醇(LDL-C)目标方面的有效性。研究纳入了 2023 年 1 月 1 日至 2023 年 12 月 31 日期间新诊断为冠心病并接受冠状动脉血运重建术的连续受试者(1275 人,平均年龄(60.0±9.7)岁,87.2% 为男性)。中位随访 99 天(四分位数间距 91-109 天)后,LDL-C 平均值为 63.9±24.3 mg/dL,67.5% 的受试者和 29.9% 的受试者 LDL-C 平均值分别为 63.9±24.3 mg/dL 和 63.9±24.3 mg/dL。
{"title":"Attainment of low-density lipoprotein cholesterol goals in patients undergoing coronary revascularization in the contemporary clinical practice.","authors":"Manish Bansal, Ravi R Kasliwal, Praveen Chandra, Rajneesh Kapoor, Nagendra Chouhan, Anil Bhan, Naresh Trehan","doi":"10.1016/j.ihj.2024.11.244","DOIUrl":"10.1016/j.ihj.2024.11.244","url":null,"abstract":"<p><p>This study aimed to assess the effectiveness of current lipid-lowering therapy in achieving low-density lipoprotein cholesterol (LDL-C) goals in Indian patients undergoing coronary revascularization. Consecutive subjects (n = 1275, mean age 60.0 ± 9.7 years, 87.2 % men) with newly diagnosed coronary artery disease and undergoing coronary revascularization during the period 1 Jan 2023 to 31 Dec 2023 were included. After a median follow-up of 99 days (interquartile range 91-109 days), the mean LDL-C was 63.9 ± 24.3 mg/dL with 67.5% and 29.9% of subjects having LDL-C <70 mg/dL and <50 mg/dL, respectively. These proportions were 70.8% and 32.1% for patients treated with high-intensity statin therapy (rosuvastatin 20-40 mg/d or atorvastatin 40-80 mg/d). Among patients treated with rosuvastatin 40 mg/d and ezetimibe 10 mg/d, 53.3% achieved LDL-C <50 mg/dL. These findings underscore the need for greater usage of combination lipid-lowering therapy and agents with high LDL-C lowering efficacy.</p>","PeriodicalId":13384,"journal":{"name":"Indian heart journal","volume":" ","pages":"414-417"},"PeriodicalIF":1.4,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11705704/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142686910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Psychological problems and burnout among healthcare workers: Impact of non-pharmacological lifestyle interventions. 医护人员的心理问题和职业倦怠:非药物生活方式干预的影响。
IF 1.4 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-11-01 Epub Date: 2024-11-20 DOI: 10.1016/j.ihj.2024.11.245
Mohit Dayal Gupta, Shekhar Kunal, Girish Mp, Ekta Chalageri, Deepak Kumar, Vivek Singh, Ankit Bansal, Vishal Batra, Jamal Yusuf, Reena Tomar, Akshita Gupta, Anubha Gupta

Objective: To evaluate role of rajyoga meditation (RYM) versus stress management counselling (SMC) in addressing burnout syndrome and resultant improvement in electrocardiogram (ECG) so as to automate burnout prediction from raw ECG data with machine learning (ML).

Methods: Healthcare providers were assigned to two groups: RYM (n = 100) or SMC (n = 102). Subjects in RYM received rajyoga for 3 months including one week offline and thereafter, virtual mode. SMC group received counselling for 1 day in offline mode and thereafter, received positive thoughts on a weekly basis. All subjects were assessed for psychological (depression, anxiety, stress scale-21 (DASS-21) and burnout syndrome (Mini Z questionnaire) along with 12-lead ECG at baseline after 4 weeks, and after 12 weeks. Based on response on question 3 of the Mini-Z questionnaire, participants were classified either as burnout or satisfied.

Results: RYM group showed significant reduction in depression, anxiety, and stress in comparison to SMC group. Burnout results display significant reduction in the RYM group in comparison to SMC group. Reduction in burnout and enhancement in satisfaction from visit-1 to visit-3: burnout visit-1 (27.2 %), visit-2 (23.8 %), visit-3 (19.3 %) and, satisfaction visit-1 (72.8 %), visit-2 (76.2 %), and visit-3 (80.7 %). ML algorithms could identify burnout patients using the raw ECG data with time-series features based classifier performing better than Ultra Short HRV features based ML classifier model.

Conclusion: AI based early diagnosis of heart's healthy status using ECG analysis may prevent development of cardiovascular disorder in the long run.

目的评估瑜伽冥想(RYM)与压力管理咨询(SMC)在解决职业倦怠综合征和改善心电图(ECG)方面的作用,以便利用机器学习(ML)从原始心电图数据自动预测职业倦怠:RYM组(100人)或SMC组(102人)。RYM组的受试者接受为期3个月的Rajyoga训练,其中包括一周的离线训练,之后接受虚拟模式训练。SMC 组接受为期 1 天的离线模式辅导,此后每周接受正念辅导。所有受试者在 4 周后和 12 周后接受心理评估(抑郁、焦虑、压力量表-21(DASS-21)和倦怠综合征(Mini Z 问卷))以及 12 导联心电图。根据对迷你 Z 问卷第 3 个问题的回答,参与者被归类为职业倦怠或满意:结果:与 SMC 组相比,RYM 组的抑郁、焦虑和压力明显减少。职业倦怠结果显示,与 SMC 组相比,RYM 组的职业倦怠明显减少。从就诊 1 到就诊 3,倦怠感减少,满意度提高:倦怠感就诊 1(27.2%)、就诊 2(23.8%)、就诊 3(19.3%),满意度就诊 1(72.8%)、就诊 2(76.2%)、就诊 3(80.7%)。基于时间序列特征的分类器比基于超短心率变异特征的ML分类器模型表现更好:结论:基于人工智能的心电图分析对心脏健康状况的早期诊断可从长远角度预防心血管疾病的发生。
{"title":"Psychological problems and burnout among healthcare workers: Impact of non-pharmacological lifestyle interventions.","authors":"Mohit Dayal Gupta, Shekhar Kunal, Girish Mp, Ekta Chalageri, Deepak Kumar, Vivek Singh, Ankit Bansal, Vishal Batra, Jamal Yusuf, Reena Tomar, Akshita Gupta, Anubha Gupta","doi":"10.1016/j.ihj.2024.11.245","DOIUrl":"10.1016/j.ihj.2024.11.245","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate role of rajyoga meditation (RYM) versus stress management counselling (SMC) in addressing burnout syndrome and resultant improvement in electrocardiogram (ECG) so as to automate burnout prediction from raw ECG data with machine learning (ML).</p><p><strong>Methods: </strong>Healthcare providers were assigned to two groups: RYM (n = 100) or SMC (n = 102). Subjects in RYM received rajyoga for 3 months including one week offline and thereafter, virtual mode. SMC group received counselling for 1 day in offline mode and thereafter, received positive thoughts on a weekly basis. All subjects were assessed for psychological (depression, anxiety, stress scale-21 (DASS-21) and burnout syndrome (Mini Z questionnaire) along with 12-lead ECG at baseline after 4 weeks, and after 12 weeks. Based on response on question 3 of the Mini-Z questionnaire, participants were classified either as burnout or satisfied.</p><p><strong>Results: </strong>RYM group showed significant reduction in depression, anxiety, and stress in comparison to SMC group. Burnout results display significant reduction in the RYM group in comparison to SMC group. Reduction in burnout and enhancement in satisfaction from visit-1 to visit-3: burnout visit-1 (27.2 %), visit-2 (23.8 %), visit-3 (19.3 %) and, satisfaction visit-1 (72.8 %), visit-2 (76.2 %), and visit-3 (80.7 %). ML algorithms could identify burnout patients using the raw ECG data with time-series features based classifier performing better than Ultra Short HRV features based ML classifier model.</p><p><strong>Conclusion: </strong>AI based early diagnosis of heart's healthy status using ECG analysis may prevent development of cardiovascular disorder in the long run.</p>","PeriodicalId":13384,"journal":{"name":"Indian heart journal","volume":" ","pages":"385-389"},"PeriodicalIF":1.4,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11705621/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142686912","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Community-level knowledge, attitudes, and practices regarding cardiovascular diseases and modifiable risk factors in India. 印度社区对心血管疾病和可改变风险因素的认识、态度和做法。
IF 1.4 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-11-01 Epub Date: 2024-11-14 DOI: 10.1016/j.ihj.2024.11.002
Kavita Singh, Dimple Kondal, Deepa Mohan, Mareesha Gandral, Sheril Rajan, Viswanathan Mohan, Mohammed K Ali, Km Venkat Narayan, Mark D Huffman, Dorairaj Prabhakaran, Nikhil Tandon

Background: Assessment of knowledge, attitudes, and practices regarding cardiovascular diseases (CVD) and cardiovascular risk factors (CVRF) is critical to inform CVD prevention strategies, but limited community-level data exist from developing countries.

Objective: To assess the knowledge, attitudes, and practices regarding CVD and CVRF and acceptability of non-physician health workers and text-message based reminders to guide CVD prevention strategies in India.

Methods: We conducted a telephone-based survey nested in the on-going Centre for Cardiometabolic Risk Reduction in South Asia (CARRS) cohort in Delhi and Chennai, India between January 2021 to February 2021. We randomly selected people with CVRF, but no established CVD and those with existing CVD from the CARRS cohort (n = 502 participants) and assessed their 1) knowledge of CVD symptoms and risk factors, 2) attitude towards non-physician health workers (NPHW) facilitated care and text-messages for healthy lifestyle, and 3) practices regarding monitoring of CVRF. We performed logistic regression analyses to investigate the factors associated with KAP.

Results: We interviewed 502 participants (283 with CVRF and 219 with CVD); 45.8 % were female, and mean age (SD) was 48.1 (11.2) years. The knowledge of heart attack symptoms, stroke symptoms, and CVRF (>75 % correct answers) were: 12.9 %, 20.7 %, and 17.3 %, respectively. Individuals with CVRF had 2.5 times lower knowledge of CVD symptoms compared to those with existing CVD. Acceptability of NPHW-facilitated care and text-messages for healthy lifestyle was 60 % and 84 %, respectively.

Conclusion: The knowledge of CVD symptoms and risk factors is below optimal levels, particularly among individuals at high risk of CVD, unskilled workers, those with lower levels of education and income. Innovative use of NPHW along with mHealth tools could potentially offer solutions to reduce the burden of CVD.

背景:评估有关心血管疾病(CVD)和心血管风险因素(CVRF)的知识、态度和实践对于制定心血管疾病预防策略至关重要,但发展中国家社区层面的数据有限:目的:在印度评估有关心血管疾病和心血管风险因素的知识、态度和实践,以及非医生卫生工作者和基于短信提醒的可接受性,以指导心血管疾病预防策略:2021 年 1 月至 2021 年 2 月期间,我们在印度德里和钦奈进行了一项电话调查,该调查嵌套于正在进行的南亚心脏代谢风险降低中心(CARRS)队列中。我们从 CARRS 队列中随机选取了有 CVRF 但未确诊心血管疾病的人群和已有心血管疾病的人群(502 人),并评估了他们的以下情况:1)对心血管疾病症状和风险因素的了解程度;2)对非医生卫生工作者(NPHW)提供的护理和健康生活方式短信的态度;3)监测 CVRF 的做法。我们对与 KAP 相关的因素进行了逻辑回归分析:我们采访了 502 名参与者(283 名 CVRF 患者和 219 名心血管疾病患者);45.8% 为女性,平均年龄(标清)为 48.1 (11.2) 岁。参与者对心脏病发作症状、中风症状和心血管风险的知晓率(>75% 正确答案)分别为分别为 12.9%、20.7% 和 17.3%。与患有心血管疾病的人相比,患有心血管疾病的人对心血管疾病症状的了解程度要低 2.5 倍。对国家卫生计生委协助的护理和健康生活方式短信的接受度分别为60%和84%:结论:对心血管疾病症状和风险因素的了解低于最佳水平,尤其是在心血管疾病高危人群、非技术工人、教育水平和收入较低的人群中。创新性地使用国家保健福祉和移动医疗工具有可能为减轻心血管疾病负担提供解决方案。
{"title":"Community-level knowledge, attitudes, and practices regarding cardiovascular diseases and modifiable risk factors in India.","authors":"Kavita Singh, Dimple Kondal, Deepa Mohan, Mareesha Gandral, Sheril Rajan, Viswanathan Mohan, Mohammed K Ali, Km Venkat Narayan, Mark D Huffman, Dorairaj Prabhakaran, Nikhil Tandon","doi":"10.1016/j.ihj.2024.11.002","DOIUrl":"10.1016/j.ihj.2024.11.002","url":null,"abstract":"<p><strong>Background: </strong>Assessment of knowledge, attitudes, and practices regarding cardiovascular diseases (CVD) and cardiovascular risk factors (CVRF) is critical to inform CVD prevention strategies, but limited community-level data exist from developing countries.</p><p><strong>Objective: </strong>To assess the knowledge, attitudes, and practices regarding CVD and CVRF and acceptability of non-physician health workers and text-message based reminders to guide CVD prevention strategies in India.</p><p><strong>Methods: </strong>We conducted a telephone-based survey nested in the on-going Centre for Cardiometabolic Risk Reduction in South Asia (CARRS) cohort in Delhi and Chennai, India between January 2021 to February 2021. We randomly selected people with CVRF, but no established CVD and those with existing CVD from the CARRS cohort (n = 502 participants) and assessed their 1) knowledge of CVD symptoms and risk factors, 2) attitude towards non-physician health workers (NPHW) facilitated care and text-messages for healthy lifestyle, and 3) practices regarding monitoring of CVRF. We performed logistic regression analyses to investigate the factors associated with KAP.</p><p><strong>Results: </strong>We interviewed 502 participants (283 with CVRF and 219 with CVD); 45.8 % were female, and mean age (SD) was 48.1 (11.2) years. The knowledge of heart attack symptoms, stroke symptoms, and CVRF (>75 % correct answers) were: 12.9 %, 20.7 %, and 17.3 %, respectively. Individuals with CVRF had 2.5 times lower knowledge of CVD symptoms compared to those with existing CVD. Acceptability of NPHW-facilitated care and text-messages for healthy lifestyle was 60 % and 84 %, respectively.</p><p><strong>Conclusion: </strong>The knowledge of CVD symptoms and risk factors is below optimal levels, particularly among individuals at high risk of CVD, unskilled workers, those with lower levels of education and income. Innovative use of NPHW along with mHealth tools could potentially offer solutions to reduce the burden of CVD.</p>","PeriodicalId":13384,"journal":{"name":"Indian heart journal","volume":" ","pages":"376-384"},"PeriodicalIF":1.4,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11705608/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142638074","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety and efficacy of protamine after transcatheter aortic valve replacement 经导管主动脉瓣置换术后使用质胺的安全性和有效性。
IF 1.4 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-01 DOI: 10.1016/j.ihj.2024.09.001
Lakshmi Durga Kumaraguruparan , Asuwin Anandaram , Kamalakkannan G. Sambandam , Yogapriya Chidambaram , Bharath Raj Kidambi , Gautam Ganesan Karthikeyan , Madhesh Kasi , Rizwan Suliankatchi Abdulkader , Sankaran Ramesh , Vadivelu Ramalingam , Ravindran Rajendran , Nagendra Boopathy Senguttuvan
Transfemoral Trans-catheter Aortic Valve Replacement (TF-TAVR) is a safe alternative to surgical aortic valve replacement (SAVR). Protamine is used to reverse heparin and reduce post-TAVR bleeding, but concerns about risks like valve thrombosis and stroke remain. This systematic review and meta-analysis, following PRISMA guidelines, found no statistically significant difference in major bleeding complications between the protamine and control groups [(3.0 % vs. 14.4 %); RR: 0.56; P = 0.16]. No differences were noted in life-threatening bleeding, blood transfusions, 30-day mortality, or stroke. Protamine appears safe post-TAVR without increasing stroke risk, but its effectiveness in reducing bleeding needs further investigation through a multicentric randomized study.
经口经导管主动脉瓣置换术(TF-TAVR)是外科主动脉瓣置换术(SAVR)的安全替代方案。原胺用于逆转肝素并减少TAVR术后出血,但对瓣膜血栓和中风等风险的担忧依然存在。这项系统回顾和荟萃分析遵循了 PRISMA 指南,发现在大出血并发症方面,丙胺组和对照组之间没有统计学意义上的显著差异[(3.0 % vs. 14.4 %);RR:0.56;P = 0.16]。在危及生命的出血、输血、30 天死亡率或中风方面没有差异。TAVR术后使用普罗胺似乎是安全的,不会增加中风风险,但其减少出血的效果还需要通过多中心随机研究进行进一步调查。
{"title":"Safety and efficacy of protamine after transcatheter aortic valve replacement","authors":"Lakshmi Durga Kumaraguruparan ,&nbsp;Asuwin Anandaram ,&nbsp;Kamalakkannan G. Sambandam ,&nbsp;Yogapriya Chidambaram ,&nbsp;Bharath Raj Kidambi ,&nbsp;Gautam Ganesan Karthikeyan ,&nbsp;Madhesh Kasi ,&nbsp;Rizwan Suliankatchi Abdulkader ,&nbsp;Sankaran Ramesh ,&nbsp;Vadivelu Ramalingam ,&nbsp;Ravindran Rajendran ,&nbsp;Nagendra Boopathy Senguttuvan","doi":"10.1016/j.ihj.2024.09.001","DOIUrl":"10.1016/j.ihj.2024.09.001","url":null,"abstract":"<div><div>Transfemoral Trans-catheter Aortic Valve Replacement (TF-TAVR) is a safe alternative to surgical aortic valve replacement (SAVR). Protamine is used to reverse heparin and reduce post-TAVR bleeding, but concerns about risks like valve thrombosis and stroke remain. This systematic review and meta-analysis, following PRISMA guidelines, found no statistically significant difference in major bleeding complications between the protamine and control groups [(3.0 % vs. 14.4 %); RR: 0.56; P = 0.16]. No differences were noted in life-threatening bleeding, blood transfusions, 30-day mortality, or stroke. Protamine appears safe post-TAVR without increasing stroke risk, but its effectiveness in reducing bleeding needs further investigation through a multicentric randomized study.</div></div>","PeriodicalId":13384,"journal":{"name":"Indian heart journal","volume":"76 5","pages":"Pages 352-354"},"PeriodicalIF":1.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142345935","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Indian heart journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1